In Brief: Vitamin E
This article was originally published in The Tan Sheet
Executive Summary
Vitamin E: "May slow or prevent kidney disease," according to a study by Gerald Appel, MD, Columbia University et al., and Roche. Released Nov. 3 at the American Society of Nephrology annual meeting in New Orleans, the study found that vitamin E doses of 30-300 mg/day in nine diabetic microalbuminuria sufferers reduced levels of soluble vascular cell adhesion molecule-1 by a mean of 14% after eight weeks of administration. VCAM-1 is a possible surrogate marker for effectiveness of interventions aimed at treating diabetic nephropathy...
|
Vitamin E: "May slow or prevent kidney disease," according to a study by Gerald Appel, MD, Columbia University et al., and Roche. Released Nov. 3 at the American Society of Nephrology annual meeting in New Orleans, the study found that vitamin E doses of 30-300 mg/day in nine diabetic microalbuminuria sufferers reduced levels of soluble vascular cell adhesion molecule-1 by a mean of 14% after eight weeks of administration. VCAM-1 is a possible surrogate marker for effectiveness of interventions aimed at treating diabetic nephropathy.... |